Kuros Biosciences AG (LON:0RHR)

Market Cap	768.89M
Revenue (ttm)	46.27M
Net Income (ttm)	-7.82M
Shares Out	n/a
EPS (ttm)	-0.27
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	486
Average Volume	2,824
Open	22.95
Previous Close	23.09
Day's Range	23.00 - 23.00
52-Week Range	1.33 - 23.00
Beta	0.92
RSI	53.32
Earnings Date	Mar 14, 2025

About Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through three segments: Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company offers MagnetOs Granules, an original advanced bone graft based on the submicron needle-shaped NeedleGrip surface technology; MagnetOs Putty, a mold use to fill bony voids for a predictable fusion; MagnetOs Easypack Putty, a ready-to-use mold ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2016
• Employees: 80
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RHR

Financial Performance

In 2023, Kuros Biosciences AG's revenue was 33.56 million, an increase of 86.61% compared to the previous year's 17.99 million. Losses were -13.73 million, -5.95% less than in 2022.

Financial numbers in CHF